According to preliminary statistics of its financial department, Zhongyuan Union Stem Cell Bio-engineering Corporation predicts a net profit owned by shareholders in 2014 to be not less than RMB 36 million after excluding extraordinary profit and loss, with earnings per share being not less than RMB 0.10 after excluding extraordinary profit and loss.